NetworkNewsBreaks

FridayMar 15, 2024 12:51 pm

NetworkNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Well Positioned to Capitalize on World’s Ongoing Energy Transition

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Canadian natural resource exploration and development company, is keen on targeting high-grade nickel sulfide developments for use in the rapidly growing electric vehicle market. “Led by a management team boasting over 100 years of combined mining and exploration experience and having raised gross proceeds of approximately C$7.5 million over the past six months to fund its incremental exploration work, Fathom Nickel has set its sights on developing two key nickel projects – the Albert Lake and Gochager Lake projects,” a recent article reads. “With total EV sales anticipated to swell from…

Continue Reading

FridayMar 15, 2024 12:14 pm

NetworkNewsBreaks – The Cannabis Place Opens Its New York City Flagship State-Licensed Dispensary in Middle Village Area

The Cannabis Place, a licensed adult-use dispensary operator in New York and New Jersey, is reporting the grand opening of its New York City flagship licensed dispensary. The location at 74-03 Metropolitan Avenue, Middle Village in Queens, will open its doors on Saturday, March 16, at 4.20 p.m. ET. “We picked this weekend to open because it’s symbolic in many ways. By opening our state-licensed dispensary in the Middle Village area of New York City, we are providing New Yorkers with access to licensed and regulated New York Cannabis products,” said Osbert Orduña, The Cannabis Place founder and CEO. “We…

Continue Reading

FridayMar 15, 2024 11:52 am

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Is Expanding Global Reach with Innovative Products

SenesTech (NASDAQ: SNES) is dramatically improving pest management technicians’ toolboxes with its patent-pending Evolve(R) soft bait birth control product for rodents, which joins the liquid ContraPest(TM) product in providing non-lethal solutions to reducing rodent populations. “The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the environment – a significant advantage over poisons used to kill rats. SenesTech’s products are the first, and still the only, such rat contraceptives registered with the U.S. Environmental Protection Agency (‘EPA’) that target both male and female rats… The company recommends using its Birth Control for…

Continue Reading

FridayMar 15, 2024 11:41 am

NetworkNewsBreaks – Tether Curates Series of Events for Its Third Annual Budtender Appreciation Week

Tether, a leading name in the Canadian cannabis industry, has curated a week-long series of opportunities, including retail visits and educational sampling events, as part of the upcoming third annual Budtender Appreciation Week. “B-Week,” an initiative created to recognize and celebrate the contributions of cannabis retail workers across Canada, is set for March 24 through March 31, 2024, promising to be bigger than ever, featuring sampling events in Vancouver, British Columbia, Oakville, Ontario, and Edmonton, Alberta. “Green Hedge and our portfolio of brands are proud to be part of Tether’s Budtender Appreciation Week at events across Canada,” said Steve Crichton,…

Continue Reading

FridayMar 15, 2024 11:37 am

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human blood plasma that form the protein corona of the gold nanocrystals of CNM-Au8(R), Clene’s investigational drug in development for the treatment of neurodegenerative diseases. “The protein corona of CNM-Au8 gold nanocrystals, tailored for brain delivery…

Continue Reading

FridayMar 15, 2024 10:30 am

NetworkNewsBreaks – Cognition Therapeutics Inc. (NASDAQ: CGTX) Closes on $11.5M Public Offering

Cognition Therapeutics (NASDAQ: CGTX), a clinical-stage company developing product candidates designed to treat neurodegenerative disorders, has closed on its previously announced underwritten public offering. The offering was comprised of 6,571,428 shares of its common stock. According to the announcement, each share of common stock was sold at $1.75 per share, resulting in approximately $11.5 million in gross proceeds before deductions, commissions and expenses. Cognition Therapeutics anticipates using the funds from the offering for research, clinical development, process development and manufacturing, working capital, capital expenditures and other general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as…

Continue Reading

ThursdayMar 14, 2024 3:22 pm

NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) Moving to Become World’s Premier Resource for High-Quality Pharmaceutical Products

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) has established five companies focused on pharmaceutical cannabis production, managing processes for plant-to-patient operations, and irrigation and greenhouse technology. “A global infrastructure and holding company in the cannabis industry, MedCana is on a mission to become the world’s premier resource for pharmaceutical cannabis products,” reads a recent article that discusses the burgeoning global medical marijuana market and the increasing trend of cannabis decriminalization around the world. “With this backdrop of growing awareness and acceptance of medical cannabis, MedCana is well positioned to become an industry leader. The company has assembled a team of…

Continue Reading

ThursdayMar 14, 2024 3:21 pm

NetworkNewsBreaks – BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) Announces Highly Promising Results from ODF Cladribine PK Study

BioNxt (CSE: BNXT) (OTCQB: BNXTF) (FSE: BXT) has announced completion of the comparative pharmacokinetic (“PK”) study for its oral dissolvable film (“ODF”) based proprietary Cladribine product for the treatment of multiple sclerosis (“MS”). The company reported that the animal PK study results are highly promising and demonstrated comparable rapid absorption and systemic exposure between BioNxt’s ODF product and the name-brand reference drug in all samples. “These results are a significant milestone for BioNxt. We have demonstrated that our ODF platform is an effective drug delivery system for cytostatic drugs via transmucosal absorption,” said BioNxt CEO Hugh Rogers. “With our recently…

Continue Reading

ThursdayMar 14, 2024 3:11 pm

NetworkNewsBreaks – Roth Capital Partners Continues Collaboration with IBN as Corporate Communications Partner for 36th Annual Conference

Roth Capital Partners (Roth MKM), a relationship-driven investment bank dedicated to serving growth companies and their investors, has selected IBN as a media sponsor for next week’s 36th Annual Roth Conference. The partnership is a continued collaboration as IBN, an innovative corporate communications firm and content distributor, has provided corporate communications and coverage for Roth events previously. The 36th Annual Roth Conference is scheduled for March 17–19, 2024, in Laguna Niguel, California. The ROTH event creates an ideal opportunity for executives from an estimated 500 selected companies to engage with potential investors during meaningful one-on-one and small-group discussions; the conference…

Continue Reading

ThursdayMar 14, 2024 3:04 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as senior vice president of finance and operations at Rain Oncology Inc., a late-stage precision oncology biotech company. In that position, he was pivotal in building and leading the company’s financial organization, resulting in significant growth…

Continue Reading